Patents by Inventor Dianne Langford

Dianne Langford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Micro-RNAs as biomarkers for subconcussive and concussive injury and therapeutic applications
    Patent number: 11739323
    Abstract: The invention includes compositions and methods useful for the diagnosis and treatment of head or brain injury in a subject in need thereof, based upon the expression level of at least one miRNA that is associated with head or brain injury.
    Type: Grant
    Filed: June 7, 2018
    Date of Patent: August 29, 2023
    Assignee: Temple University-Of The Commonwealth System of Higher Education
    Inventors: Matthew B. Hudson, Dianne Langford, John Jeka, Ryan Tierney
  • TARGETING THE BAG FAMILY FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE
    Publication number: 20220088127
    Abstract: Compositions in the prevention or treatment of neurodegenerative diseases or disorders associated with human immunodeficiency virus infection include agents which modulate the interactions of HIV Tat and Bcl-2 associated athanogene (BAG) molecules.
    Type: Application
    Filed: January 15, 2020
    Publication date: March 24, 2022
    Inventors: Jennifer Gordon, Kamel Khalili, T. Dianne Langford, Taha Mohseni Ahooyi
  • MICRO-RNAS AS BIOMARKERS FOR SUBCONCUSSIVE AND CONCUSSIVE INJURY AND THERAPEUTIC APPLICATIONS
    Publication number: 20180355356
    Abstract: The invention includes compositions and methods useful for the diagnosis and treatment of head or brain injury in a subject in need thereof, based upon the expression level of at least one miRNA that is associated with head or brain injury.
    Type: Application
    Filed: June 7, 2018
    Publication date: December 13, 2018
    Inventors: Matthew B. Hudson, Dianne Langford, John Jeka, Ryan Tierney
  • METHOD FOR DETERMINING DISEASE SEVERITY IN TAUOPATHY-RELATED NEURODEGENERATIVE DISORDERS
    Publication number: 20150147766
    Abstract: A method for determining disease severity in a subject afflicted with a tauopathy-related neurodegenerative disease comprises detecting the level of a PINCH protein or isoform thereof in a test sample comprising brain tissue or cerebrospinal fluid. The PINCH protein level in the test sample indicates the relative severity of the tauopathy-related neurodegenerative disease afflicting the subject.
    Type: Application
    Filed: May 23, 2013
    Publication date: May 28, 2015
    Inventors: Teresa Dianne Langford, Salim Merali